It helps by increasing your metabolism, building lean muscle, improving how your body handles insulin, and aiding in long-term weight management
Trade-offs: weaker clinical evidence, insurance hurdles, purity concerns
Other peptides worth comparing: Liraglutide daily GLP-1 agonist, less effective than both but FDA-approved since 2014 Retatrutide triple agonist (GLP-1/GIP/Glucagon), showing up to 24% weight loss in Phase 2 trials AOD-9604 HGH fragment for fat metabolism, much milder effect The Bottom Line Tirzepatide has the edge in raw efficacy and tolerability based on trial data
Sulfur consumption could affect symptom severity, for better or worse, in people with certain genetic variants
Contrast: DSIP is positioned as cleaner on next-day cognition (anecdotal), though evidence remains limited